Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jan;99(5):e19026.
doi: 10.1097/MD.0000000000019026.

Shallow periorbital injection of triamcinolone acetonide in treatment of lower eyelid entropion related to thyroid-associated ophthalmopathy: Three case reports

Fei Mo  1 , Dongdong Xu  1 , Haiyan Xu  1 , Gang Li  2 , Yizhuo Gao  1 , Hui Li  1
Affiliations
Case Reports

Shallow periorbital injection of triamcinolone acetonide in treatment of lower eyelid entropion related to thyroid-associated ophthalmopathy: Three case reports

Fei Mo et al. Medicine (Baltimore). 2020 Jan.

Abstract

Introduction: Entropion and secondary trichiasis can lead to irritative symptoms and essential damage of ocular surface. There is no literature reporting the lower eyelid entropion related to thyroid-associated ophthalmopathy (TAO), let alone the treatment. Treatment based on etiology may yield effective and sustained results. We report 3 case reports of lower eyelid entropion associated with TAO, and provide an effective and persistent alternative to cure this entropion via the administration of shallow periorbital injections of triamcinolone acetonide (TA).

Patient concerns: Three patients presented irritative symptoms of ocular surface and diplopia.

Diagnosis: According to thyroid dysfunction, physical examination, and imaging findings of extraocular muscle involvement, TAO and unilateral or bilateral lower eyelid entropion were diagnosed.

Interventions: We administered shallow periorbital injections of TA to the affected eye at 3- to 4-week intervals depending on clinical response.

Outcomes: All patients underwent complete correction of the lower eyelid entropion and no recurrence was found.

Conclusion: The cause of lower eyelid entropion related to TAO might be the immunoinflammatory reaction of the lower eyelid retractors, enhancing the traction of pulling the lower eyelid inferoposteriorly. This condition can be treated with shallow periorbital injections of TA. Histopathological evidence and randomized controlled trials are expected to confirm our hypothesis.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1
Figure 1
(A) Pre-treatment of the left eye. (B) Post-treatment of the left eye. (C) Pre-treatment of the right eye. (D) Post-treatment of the right eye.
Figure 2
Figure 2
(A) Pre-treatment of the right eye. (B) Post-treatment of the right eye. (C) Pre-treatment of the left eye. (D) Post-treatment of the left eye.
Figure 3
Figure 3
(A) Pre-treatment. (B) Post-treatment.
See this image and copyright information in PMC

References

    1. Hahn S, Desai SC. Lower lid malposition: causes and correction. Facial Plast Surg Clin North Am 2016;24:163–71. - PubMed
    1. Grove AS., Jr Upper eyelid retraction and Graves’ disease. Ophthalmology 1981;88:499–506. - PubMed
    1. Cockerham KP, Hidayat AA, Brown HG, et al. Clinicopathologic evaluation of the Mueller muscle in thyroid-associated orbitopathy. Ophthalmic Plast Reconstr Surg 2002;18:11–7. - PubMed
    1. Most SP, Mobley SR, Larrabee WF., Jr Anatomy of the eyelids. Facial Plast Surg Clin North Am 2005;13:487–92. v. - PubMed
    1. Kakizaki H, Malhotra R, Madge SN, et al. Lower eyelid anatomy: an update. Ann Plast Surg 2009;63:344–51. - PubMed

Publication types